Quanscient Oy – Trademark Portfolio
Entity Type: 99
Quanscient Oy holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 7 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 5 trademarks are registered and 2 are pending. Notable registered marks include QUANSCIENT, SPARSELIZARD, QUANTUM NATIVE, and QUANSCIENT.ALLSOLVE. The owner is based in Tampere.
Åkerlundinkatu 8
Tampere 33100 , FI
Showing of trademarks Trademarks
Trademark Classifications
Quanscient Oy's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Quanscient Oy have?
Quanscient Oy has 7 U.S. trademarks filed with the USPTO. Of these, 5 registered, 2 pending.
What trademark classes does Quanscient Oy file in?
Quanscient Oy files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 9 (Computers & Electronics). Class 35 covers advertising; business management; business administration; office functions.
What are Quanscient Oy's most well-known trademarks?
Quanscient Oy's registered trademark portfolio includes well-known marks such as QUANSCIENT, SPARSELIZARD, QUANTUM NATIVE, and QUANSCIENT.ALLSOLVE. These are among 5 currently registered trademarks in the portfolio.
What is Quanscient Oy's trademark registration success rate?
Quanscient Oy has a 100% trademark registration rate, with 5 out of 5 resolved applications resulting in successful registration. Currently, 2 applications are pending review.